Authorizes the 10b5-1 share buyback program
DALLAS, May 19, 2022 /PRNewswire/ — SWK Holdings Corporation (Nasdaq: SWKH) (“SWK” or the “Company”), a life sciences-focused specialty finance company serving small and medium commercial enterprises, announced today today that it had filed a Universal Registration Statement on Form S-3 with the Securities and Exchange Commission (“SEC”). Once declared effective by the SEC, SWK may from time to time issue various types of securities, including common stock, preferred stock, senior or unsecured debt and/or warrants, up to to a total amount of $200 million. Among other things, the Company intends to issue senior and/or unsecured debt pursuant to the registration statement, although at this time there is no assurance that the Company will pursue or complete any debt offer.
SWK also announced today that its board of directors has authorized the company to repurchase up to a total of $10.0 million common shares of the Company from time to time until May 15, 2023via a “10b5-1 trading plan” in accordance with the Rule 10b-18 under the Securities Exchange Act of 1934. The actual timing, number and value of shares repurchased under the program will depend on several factors, including the constraints specified in Trading Plan 10b5-1, price and general market conditions. There is no guarantee as to the exact number of shares that will be redeemed under the exchange plan.
“We believe this pending registration statement allows SWK to effectively capitalize our balance sheet and continue to grow our core specialty finance business to help life science companies meet their growth capital needs,” said the CEO. Winston Black mentioned. “Furthermore, we continue to view the buyback of our shares as an attractive and prudent use of our capital that is in the best interest of our shareholders.”
This press release does not constitute an offer to sell or the solicitation of an offer to buy, and there will be no sale of the Securities in any state in which such offer, solicitation or sale would be unlawful prior to registration. or qualification under titles. law of such State. Any offer of the securities covered by the shelf registration statement will be made only by means of a prospectus and any accompanying prospectus supplement relating to such offering. A copy of the prospectus included in the registration statement may be obtained on the SEC’s website at www.sec.gov.
About SWK Holdings Corporation
SWK Holdings Corporation is a specialty finance company focused on the global healthcare industry. SWK partners with ethical product distributors and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for SWK’s business partners and investors. SWK believes that its funding structures achieve the optimal partnership for companies, institutions and inventors seeking capital for expansion or capital and succession planning by allowing its partners to monetize flows future cash flows with minimal dilution of their holdings. SWK also owns Enteris BioPharma, whose drug delivery technologies Peptelligence® and ProPerma™ create oral formulations of small molecules based on class II, III and IV peptides and BCS. With Enteris, SWK has the opportunity to grow its financial business by actively building a wholly owned portfolio of milestones and royalties through licensing activities. Additional information on the life sciences financing market is available on the Company’s website at www.swkhold.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. “plans”, “will”, “may”, “looks ahead”, “intends”, ” direction”, “future” or similar expressions are forward-looking statements. Because these statements reflect SWK’s current opinions, expectations and beliefs regarding future events, these forward-looking statements involve risks and uncertainties. Investors should note that numerous factors, as more fully described under “Risk Factors” and elsewhere in Forms 10-K, Forms 10-Q and 8-K filed by SWK with the Securities and Exchange Commission and as set forth elsewhere herein, could affect the future financial results of the Company and could cause actual results to differ materially from those expressed in such forward-looking statements. The forward-looking statements contained in this press release are qualified by these risk factors. These are factors that, individually or collectively, could cause the Company’s actual results to differ materially from expected and historical results. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise..
SOURCESWK Holdings Corporation